Found 8 diabetes-and-metabolism trials
A listing of diabetes-and-metabolism medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Sort by:
The research study is being conducted to better understand Cystic-Fibrosis Related Diabetes (CFRD) and to see the effects of an analog of the gut incretin hormone, GLP-1 (dulaglutide), has on individuals like with abnormal glucose tolerance. GLP-1 (dulaglutide) helps the pancreas release insulin, which controls blood sugar levels from getting …
In T1D the body’s immune system destroys insulin producing cells called beta cells. This meansthe body cannot produce enough insulin to control the amount of sugar in the blood. Beta cellsare located in the pancreas and are part of clusters of cells called pancreatic islets.These cells produce hormones such as …
Are you at risk for type 1 diabetes?Are you willing to receive a phone call every 6 months?For patients treated with TZIELD AND NOT treated with TZIELDYou may qualify to participate in an observational research studyAn observational study (you will not receive any experimental medication)Does not require on-site visitsParticipation will …
Do you have Type 1 Diabetes for more than 10 years? The purpose of this study is to learn how to improve hypoglycemia unawareness - a condition where people with T1D may not be able to tell how low their blood sugar levels are. Hypoglycemia unawareness happens because their body’s response …
Emergence and Progression of Abnormal Glucose Tolerance in Cystic Fibrosis (Aim 1) (CF Longitudinal)
The purpose of this research study is to test how high blood sugar develops and worsens over time in some people with cystic fibrosis.If you agree to take part, your participation can last for up to 7 years.As a participant in this research, all participants will:Complete overnight fastingComplete Mixed Meal …
The purpose of this study is to learn about and compare the effects of cadisegliatin (also called “TTP399”) compared to placebo to find out which is better for reducing the episodes of low blood sugar (hypoglycemia) related to type 1 diabetes, lowering HbA1c, and to see how safe cadisegliatin is …
This study is being done to find out if inhaled insulin given for a meal is safer and better to use than a bolus of insulin through the pump when exercising following a meal.
The primary objectives are to determine the pharmacokinetic (PK) and pharmacodynamic (PD) response of dorzagliatin 75 mg twice daily following 7-day administration in individuals with PI-CF and abnormal glucose tolerance (EGI, IGT or CFRD) when compared to 7-day administration of placebo according to a randomized, double-blind cross-over study design. The …
Please choose between Voice or SMS based delivery of verification code
or